Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study. Am J Clin Oncol. 2000 Aug; 23(4):355-7.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Anemia
Anemia
Antineoplastic Agents
Antineoplastic Agents
Cohort Studies
Cohort Studies
Disease Progression
Disease Progression
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Injections, Intravenous
Injections, Intravenous
Leiomyosarcoma
Leiomyosarcoma
Leukopenia
Leukopenia
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasm Staging
Neutropenia
Neutropenia
Remission Induction
Remission Induction
Thrombocytopenia
Thrombocytopenia
Topotecan
Topotecan
Uterine Neoplasms
Uterine Neoplasms
authors with profiles
Robert S Mannel